Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 June 2022 | Story Lacea Loader
UFS drops wearing of masks on campus

The management of the University of the Free State (UFS) has taken note of the announcement by the Minister of Health, Dr Joe Phaahla, in the Government Gazette on 22 June 2022, in which COVID-19 regulations were repealed.

Minister Phaahla stated that, as from 22 June, South Africans no longer have to wear masks, and that limits on gatherings and border checks for COVID-19, as well as the need to be vaccinated in order to enter South Africa, have also been dropped.

The UFS COVID-19 Regulations and Required Vaccination Policy has created an environment that the university management regards as safe. This, together with yesterday’s announcement by the Minister, was considered, and a decision was made that the wearing of masks on campus or in any building on campus is no longer compulsory.

However, the UFS COVID-19 Regulations and Required Vaccination Policy remains in place. Campus access control is still in place, and staff, students, and visitors are expected to upload a COVID-19 vaccination certificate or a negative PCR or antigen test result to obtain access to the campuses.

The wearing of masks is still recommended and will be of value especially in the following instances:

1.     For immune-compromised staff, students, and visitors
2.     For persons who are ill with, e.g., flu, colds, coughs, etc.

In the case of staff and students working in public and private hospitals, or any other external laboratory/facility, the wearing of masks is determined by the hospital or the external laboratory/facility and not by the UFS. In any other environment where students or staff are under the regulations of external organisations, these regulations will take precedence. 

Staff and students are encouraged to feel free to continue wearing masks, including those with comorbidities, as masks have been shown to be helpful in preventing the spread of respiratory diseases. Good health-care behaviour remains important as COVID-19 is still a reality.

The university management will decide in due course on the possible upliftment of restrictions on public gatherings.

Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za

News Archive

UFS Expert: Prof Felicity Burt investigates zoonotic and arboviruses
2017-12-13


 Description: Burt read more 2 Tags: Arboviruses, Felicity Burt, Crimean-Congo haemorrhagic fever, viruses  

Prof Felicity Burt recently received a B-rating from the
National Research
Foundation.
Photo: Sonia Small

Prof Felicity Burt is from the Division of Virology in the Faculty of Health Sciences at the University of the Free State (UFS), as well as the National Health Laboratory Services (NHLS). She currently holds an NRF-DST South African Research Chair in vector-borne and zoonotic diseases.  Professor Burt and her research group investigate arboviruses and zoonotic viruses. 

Prof Burt’s research primarily focuses on host immune responses to arboviral infections specifically characterising humoral and cellular immune responses in patients with infections such as Crimean-Congo haemorrhagic fever (CCHF) virus and Sindbis virus; epitope discovery for development of diagnostic tools; development of molecular and serological assays for surveillance purposes; virus discovery; and the development of vaccines.

Raising awareness of these viruses, defining associated diseases, and developing tools for surveillance programmes will contribute to understanding these pathogens as well as the public health implications.

Leads research group in papilloma viruses
Arboviruses cause outbreaks of disease in South Africa annually. Outbreaks are usually associated with heavy rainfall favouring the breeding of mosquitos, but these viruses also have the capacity to spread and become endemic in new areas where competent vectors are present. 
In addition, she is leading a research group that investigates human papilloma viruses (HPV) associated with head and neck cancers and recurrent laryngeal papilloma.

The focus of this research group is to ascertain the genotypes of HPV causing these diseases, identification of novel biomarkers for early detection, and complete genome sequencing for molecular characterisation of HPV isolates.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept